Yanyan Feng

Dr. Yanyan Feng


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RWRong Wang
Rong Wang
PWPiaopiao Wen
Piaopiao Wen
GYGanglong Yang
Ganglong Yang
YFYanyan Feng
Yanyan Feng
YMYuanyuan Mi
Yuanyuan Mi
YCYongquan Chen
Yongquan Chen
Castration-resistance of prostate cancer is one of the most challenging clinical problems. In the present study, we have performed proteomics and glycomics using LNCaP model. Growth differentiation factor-15 (GDF15) level is increased in androgen receptor (AR) inhibitor-resistant cells and the inhibitory effect of GDF15 on epithelial growth factor receptor (EGFR) pathway is relieved by GDF15 N70 glycosylation. Interference of GDF15 (siRNA or N70Q dominant negative) or EGFR pathway (inhibitor or siRNA for EGFR, SRC or ERK) decreases the resistant-cell survival in culture and tumor growth in mice. Our study reveals a novel regulatory mechanism of prostate cancer AR inhibitor resistance, raises the possibility of AR/SRC dual-targeting of castration-resistance of prostate cancer, and lays foundation for the future development of selective inhibitors of GDF15 glycosylation.

6 November 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LLLin Li
Lin Li
LFLixin Fu
Lixin Fu
LZLiwen Zhang
Liwen Zhang
YFYanyan Feng
Yanyan Feng
Primary membranous nephropathy (MN) is a rare autoimmune cause of kidney failure. Observational studies have suggested some relationship between virus infection and primary MN, but the association remains unclear. The current study performed a two‑sample Mendelian randomization (MR) analysis to explore the causal association between varicella‐zoster virus (VZV) infection (chickenpox and shingles) and primary MN using genome‑wide association studies (GWASs) summary statistics. The exposure datasets containing chickenpox and shingles were obtained from the GWASs conducted by the 23andMe cohort. And summary‐level statistics for primary MN were used as the outcome dataset, comprising 2150 cases and 5829 controls from European Ancestry. The inverse variance weighted method was adopted as the main analysis. As a result, we found that both genetically determined chickenpox (odds ratio [95% confidential interval] = 3.61 [1.74–7.50], p = 5.59e−04) and shingles (p = 7.95e−03, odds ratio [95% confidential interval] = 2.49 [1.27–4.91]) were causally associated with an increased risk of developing primary MN. In conclusion, our MR findings provided novel genetic evidence supporting the causal effect of VZV infection on primary MN. Further studies are needed to elucidate the underlying mechanisms mediating the causal association.

1 January 2025 in Dermatologic Therapy
Verified
Journal Article
Open access
HSHuanyu Shi
Huanyu Shi
XWXiaolin Wang
Xiaolin Wang
XLXueli Li
Xueli Li
YFYanyan Feng
Yanyan Feng
Androgenetic alopecia (AGA) affects about half of men and many women worldwide, yet current treatments often fall short. This review summarizes key pathogenic mechanisms of AGA, centering on three interconnected processes: the dihydrotestosterone–prostaglandin D2 (DHT–PGD2) loop, oxidative stress and inflammation, and lipid metabolism dysregulation. These factors converge to suppress Wnt/β‐catenin signaling, the core pathway for hair growth. DHT and PGD2 reinforce each other to drive follicular miniaturization via CXXC5 and GSK‐3β activation. Oxidative stress and chronic inflammation—exacerbated by scalp microbiome imbalance, notably excess Cutibacterium acnes and Malassezia—further damage the follicular environment. Suppressed PPARγ signaling disrupts adipocyte‐follicle crosstalk, reducing growth factor support. These insights reveal emerging therapeutic targets, including DP2 antagonists, CXXC5/GSK‐3β inhibitors, antioxidants, microbiome modulators, and PPARγ agonists. By integrating molecular, microbial, and metabolic perspectives, this review outlines a framework for multitarget strategies to address the limitations of existing AGA treatments.

6 May 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
YFYanyan Feng
Yanyan Feng
CSChuanyu Sun
Chuanyu Sun
LZLifeng Zhang
Lifeng Zhang
HWHongyuan Wan
Hongyuan Wan
HZHangsheng Zhou
Hangsheng Zhou
YMYuanyuan Mi
Yuanyuan Mi
There is increasing evidence that coatomer protein complex subunit beta 2 (COPB2) plays an important role in various cancer types. This study explored the role and the downstream mediators of COPB2 in prostate cancer (PCa). The expression of COPB2 was determined by the Cancer Genome Atlas database and enzyme-linked immunosorbent assay. COPB2 expression was upregulated in PCa tissues and correlated with Gleason score, biochemical recurrence, and poor prognosis. The functional roles of COPB2 in PCa were verified through a series of experiments. Knocking down COPB2 expression inhibited the growth and clonogenesis of PCa cells, promoted cell apoptosis, and inhibited the ability of scratch repair, invasion of PCa cells, and tumor growth in Nude mice. To analyze downstream signaling pathways, ingenuity pathway analysis, GSEA, and whole-genome expression spectrum GeneChip analysis were used. Western blot revealed that COPB2 expression promoted the proliferation and invasion of PCa cells by regulating the MAPK/TGF-β signaling pathway. The interacting protein (nuclear protein 1, NUPR1) was identified via Co-IP, real-time PCR, Western blot, and TCGA database in sampled tissues. The expressions of the interaction proteins NUPR1 and COPB2 were negatively regulated by each other. COPB2 could be a new biomarker for PCa diagnosis and monitoring and to provide a theoretical basis for identifying effective drug intervention targets through in-depth mechanistic studies.

6 October 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
LLLin Li
Lin Li
BPBaoqiang Pei
Baoqiang Pei
YFYanyan Feng
Yanyan Feng
Previous studies reported inconsistent results regarding the association between keratinocyte carcinoma (KC) and exogenous hormone therapy. This study aimed to investigate the association between the use of exogenous sex hormones and the risk of KC among women. The databases of PubMed, Ovid Medline, Cochrane, and Web of Science were searched until May 2023. A total of 5293 patients with KC and 106,424 controls were included for analysis. The meta-analysis indicated that oral contraceptives (OC) and hormonal replacement therapy (HRT) use were associated with an increased risk of squamous cell carcinoma (SCC) (OR/RR = 1.25, 95% CI 1.10 to 1.43, I2 = 41.6%, p = 0.080). Subgroup analysis showed that OC use increased the risk of SCC (OR/RR = 1.37, 95% CI 1.15 to 1.63), whereas no significant association was shown between HRT use and risk of SCC (OR/RR = 1.13, 95% CI 0.93 to 1.37). Additionally, OC and HRT use were linked to an increased risk of basal cell carcinoma (BCC) (OR/RR = 1.16, 95% CI 1.09 to 1.25, I2 = 30.1%, p = 0.188). Further subgroup analysis suggested both OC and HRT use were associated with an increased risk of BCC (OC: OR/RR = 1.13, 95% CI 1.01 to 1.25; HRT: OR/RR = 1.19, 95% CI 1.09 to 1.30). In conclusion, our findings support the hypothesis that the risk of KC among women may be affected by the use of exogenous hormones.

27 November 2025 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
KZKejia Zhang
Kejia Zhang
YFYanyan Feng
Yanyan Feng
XZXiaoyu Zhang
Xiaoyu Zhang
XHXingyan He
Xingyan He
SQSichun Qin
Sichun Qin
YLYuxi Liang
Yuxi Liang
Background: Rosacea is a chronic inflammatory skin disease characterized by vascular and neurological dysregulation, presenting with diverse clinical subtypes whose pathological mechanisms remain incompletely elucidated. Recent studies suggest that metabolic dysregulation may play a key role in disease onset and progression; however, systematic metabolomic studies targeting different subtypes remain limited. Objective: This study employed untargeted metabolomic analysis to systematically compare plasma metabolic characteristic differences between patients with erythematotelangiectatic rosacea (ETR), papulopustular rosacea (PPR), and healthy controls (HC), aiming to identify potential disease biomarkers and provide new insights for understanding the pathogenesis of rosacea. Methods: Ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) was used to compare metabolic profiles of plasma samples from ETR, PPR, and HC groups. Key differential metabolites identified were subjected to correlation analysis with disease severity and skin physiological parameters. Results: ETR patients primarily involved amino acid metabolism, carbon metabolism, and cholesterol metabolism pathways, with key metabolites including upregulated SSA and 2,3-DHPA, and downregulated TCDCA and Met. PPR patients primarily involved tryptophan and linoleic acid metabolism pathways, with key metabolites including upregulated 12-HSA, DGLA, and 5-ALA, and downregulated 5-HTP and 3-HPPA. Metabolic differences between different rosacea subtypes were associated with steroid hormone biosynthesis. DGLA showed positive correlation with disease severity, while 5-HTP showed negative correlation with disease severity. Met was closely related to skin barrier function. Both 12-HSA and DGLA showed positive correlation with sebum secretion. Conclusion: These findings elucidate the metabolic characteristics of rosacea and their associations with disease severity and skin physiological parameters, providing new theoretical foundation and potential targets for subtype diagnosis and precision treatment of the disease.